Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy and Surgery in Bilateral or Predisposed Wilms Tumor
NCT00945009Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Aug 2009
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Targeted Liposomes
- Countries
- 6
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection, actinomycin D, pegylated liposomal doxorubicin in Wilms' tumor, diffuse hyperplastic perilobar nephroblastomatosis (DHPLN), sponsored by Children's Oncology Group. Started Aug 2009; status: completed.
02
Drugs
vincristine sulfate liposome injectionactinomycin Dpegylated liposomal doxorubicin
03
Conditions
Wilms' tumordiffuse hyperplastic perilobar nephroblastomatosis (DHPLN)
Beyond the preview
Go deeper on NCT00945009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945009.